BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171215
DTEND;VALUE=DATE:20180117
DTSTAMP:20260729T180315
CREATED:20171215T171216Z
LAST-MODIFIED:20171215T172131Z
UID:19463-1513296000-1516147199@ces.b2sg.org
SUMMARY:Research Associate
DESCRIPTION:1. Basic Cancer Research:\n We seek junior and senior investigators with innovative basic cancer biology programs that emphasize mechanistic approaches. Areas of interest include signal transduction\, stem cells\, gene regulation/transcription\, chromatin/epigenetics\, genome stability/DNA repair\, cancer metabolism\, cancer genetics\, metastasis\, epithelial cancers\, tumor immunology\, hematologic malignancies\, pediatric/youth cancers\, and mechanisms of therapy resistance. Successful applicants will align with and benefit from our cancer disease-oriented research teams (DOTs)\, which facilitate translation of basic science discoveries through collaborative team science approaches. \n2. Translational Cancer Research:\n This broad-based recruitment seeks outstanding scientists in a number of areas including\, but not limited to: animal models\, signal transduction\, cancer genetics\, target validation\, drug discovery/validation\, epigenetics & gene expression\, DNA damage & repair\, tumor immunology\, cancer initiating cells\, and clinical cancer research. Candidates whose scientific interests dovetail with the clinical strengths of the HCI DOTs are particularly encouraged to apply. \n3. Cancer Control and Population Sciences:\n We seek outstanding scientists in a number of areas including\, but not limited to: cancer prevention (including behavioral interventions)\, cancer epidemiology\, with emphasis on molecular/clinical epidemiology or genetic epidemiology\, cancer survivorship\, exercise and cancer\, health outcomes\, and risk communication. We are looking for collaborative and engaged colleagues who are interested in advancing their career through interdisciplinary team science. \nCandidates should submit a curriculum vitae\, cover letter containing a description of professional experience (including scientific accomplishments\, leadership responsibilities and 3 references)\, and a 3 page research plan. Review begins in the Fall of 2016 and continues until the positions are filled or the search is closed. \nPlease send all materials to:\nHuntsman Cancer Institute\nAttn: Recruitment Office\, Room 5160\n2000 Circle of Hope\, Salt Lake City\, UT 84112-5550\nEmail: hci.recruitment@hci.utah.edu
URL:https://ces.b2sg.org/event/utah-15dec17/
LOCATION:University of Utah\, 201 Presidents Cir\, Salt Lake City\, 84112\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/08/university-of-utah_416x416.png
END:VEVENT
END:VCALENDAR